Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Cyclophosphamide for multiple sclerosis.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
CCSVI and MS: no meaning, no fact.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Myelination of the nervous system: mechanisms and functions.
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.

Pages